Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.607
-0.042 (-6.53%)
At close: Feb 21, 2025, 4:00 PM
0.610
+0.003 (0.43%)
After-hours: Feb 21, 2025, 7:06 PM EST
Elevation Oncology Market Cap
Elevation Oncology has a market cap or net worth of $35.91 million as of February 21, 2025. Its market cap has decreased by -72.86% in one year.
Market Cap
35.91M
Enterprise Value
-36.14M
1-Year Change
-72.86%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since the IPO on June 25, 2021, Elevation Oncology's market cap has decreased from $365.16M to $35.91M, a decrease of -90.17%. That is a compound annual growth rate of -46.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 35.91M | 7.96% |
| Dec 31, 2024 | 33.26M | 46.03% |
| Dec 29, 2023 | 22.78M | 2.97% |
| Dec 30, 2022 | 22.12M | -84.16% |
| Dec 31, 2021 | 139.65M | -61.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.21B |
| UnitedHealth Group | 462.37B |
| Johnson & Johnson | 384.45B |
| Novo Nordisk | 370.84B |
| AbbVie | 354.62B |
| Abbott Laboratories | 230.98B |
| AstraZeneca | 227.07B |
| Merck & Co. | 221.80B |